Department of Urology, University of California, Davis, School of Medicine, Sacramento, CA, USA.
Department of Urology, University of California, Davis, School of Medicine, Sacramento, CA, USA.
Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10.
Although different prognostic factors for patients with renal cell carcinoma (RCC) and vena cava tumor thrombus (TT) have been studied, the prognostic value of histologic subtype in these patients remains unclear.
We analyzed the impact of histologic subtype on cancer-specific survival (CSS).
DESIGN, SETTINGS, AND PARTICIPANTS: We retrospectively analyzed the records of 1774 patients with RCC and TT who underwent radical nephrectomy and tumor thrombectomy from 1971 to 2012 at 22 US and European centers.
Multivariable ordered logistic and Cox regression models were used to quantify the impact of tumor histology on CSS.
Overall 5-yr CSS was 53.4% (confidence interval [CI], 50.5-56.2) in the entire group. TT level (according to the Mayo classification of macroscopic venous invasion in RCC) was I in 38.5% of patients, II in 30.6%, III in 17.3%, and IV in 13.5%. Histologic subtypes were clear cell renal cell carcinoma (cRCC) in 89.9% of patients, papillary renal cell carcinoma (pRCC) in 8.5%, and chromophobe RCC in 1.6%. In univariable analysis, pRCC was associated with a significantly worse CSS (p<0.001) compared with cRCC. In multivariable analysis, the presence of pRCC was independently associated with CSS (hazard ratio: 1.62; CI, 1.01-2.61; p<0.05). Higher TT level, positive lymph node status, distant metastasis, and fat invasion were also independently associated with CSS.
In our multi-institutional series, we found that patients with pRCC and vena cava TT who underwent radical nephrectomy and tumor thrombectomy had significantly worse cancer-specific outcomes when compared with patients with other histologic subtypes of RCC. We confirmed that higher TT level and fat invasion were independently associated with reduced CSS.
尽管已经研究了肾细胞癌(RCC)和腔静脉肿瘤血栓(TT)患者的不同预后因素,但这些患者的组织学亚型的预后价值尚不清楚。
我们分析了组织学亚型对癌症特异性生存(CSS)的影响。
设计、地点和参与者:我们回顾性分析了 1971 年至 2012 年期间在 22 个美国和欧洲中心接受根治性肾切除术和肿瘤血栓切除术的 1774 例 RCC 和 TT 患者的记录。
多变量有序逻辑和 Cox 回归模型用于量化肿瘤组织学对 CSS 的影响。
总体而言,整个组的 5 年 CSS 为 53.4%(置信区间[CI],50.5-56.2)。TT 水平(根据 RCC 中宏观静脉侵犯的 Mayo 分类)在 38.5%的患者中为 I 级,在 30.6%的患者中为 II 级,在 17.3%的患者中为 III 级,在 13.5%的患者中为 IV 级。组织学亚型为透明细胞肾细胞癌(cRCC)占 89.9%,乳头状肾细胞癌(pRCC)占 8.5%,嫌色细胞肾细胞癌占 1.6%。在单变量分析中,与 cRCC 相比,pRCC 与 CSS 显著相关(p<0.001)。在多变量分析中,pRCC 与 CSS 独立相关(风险比:1.62;CI,1.01-2.61;p<0.05)。较高的 TT 水平、阳性淋巴结状态、远处转移和脂肪侵犯也与 CSS 独立相关。
在我们的多机构系列中,我们发现接受根治性肾切除术和肿瘤血栓切除术的 pRCC 和腔静脉 TT 患者的癌症特异性生存结果明显差于其他 RCC 组织学类型的患者。我们证实,较高的 TT 水平和脂肪侵犯与 CSS 降低独立相关。